T 2080/13 (Bone mineralisation/UCB PHARMA) of 08.09.2017
- European Case Law Identifier
- ECLI:EP:BA:2017:T208013.20170908
- Date of decision
- 8 September 2017
- Case number
- T 2080/13
- Petition for review of
- -
- Application number
- 06011535.9
- IPC class
- C12N 15/12
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Compositions and methods for increasing bone mineralisation
- Applicant name
- UCB Pharma S.A.
- Opponent name
- Mereo Biopharma 3 Limited
Eli Lilly and Company
Laudens - Board
- 3.3.08
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 113(2)
- Keywords
- Basis of decision - revocation of the patent at request of the patent proprietor
- Catchword
- -
- Cited cases
- T 0073/84
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.